Related Experiment Video
Updated: Apr 21, 2026
04:49
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
2.0K
Metabolites and Polycystic Ovarian Syndrome: A Mendelian Randomization Study
Na Aru1, Yuntian Chen2, Tian Li3,4
1Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
Current Medicinal Chemistry
|April 20, 2026
Summary
This study used Mendelian randomization to find causal links between metabolites and polycystic ovarian syndrome (PCOS). Five metabolites, including methionine sulfoxide and theophylline, were significantly associated with PCOS risk.
Area of Science:
- Metabolomics
- Genetic Epidemiology
- Reproductive Health
Background:
- Polycystic ovarian syndrome (PCOS) is a prevalent endocrine disorder affecting women globally.
- The precise causal links between specific metabolites and PCOS development are not fully understood.
Purpose of the Study:
- To investigate the causal relationships between a wide range of metabolites and the risk of developing PCOS.
- To identify potential metabolic biomarkers for PCOS.
Main Methods:
- A two-sample Mendelian randomization (MR) analysis was performed.
- Utilized genetic variants as instrumental variables to assess causality between 1352 metabolites and PCOS.
- Employed inverse-variance weighted (IVW) and sensitivity analyses, including reverse MR.
Main Results:
- Five metabolites showed significant associations with PCOS risk: increased methionine sulfoxide and piperine metabolite C16H19NO3, and decreased theophylline, 4-hydroxycoumarin, and tyramine O-sulfate.
- Reverse MR analysis confirmed a significant association between PCOS and decreased tyramine O-sulfate levels.
- Sensitivity analyses supported the robustness of the findings.
Conclusions:
- Establishes causal links between specific metabolites (e.g., methionine sulfoxide, theophylline, tyramine O-sulfate) and PCOS.
- Suggests roles for oxidative stress, dietary factors, and gut microbiome in PCOS pathogenesis.
- Identifies potential targets for PCOS prevention and treatment, warranting further validation in diverse populations.
Related Concept Videos
02:07Oogenesis
71.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.8K
01:29Pharmacogenomics: Identification of New Drug Targets
108
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
108
01:27Pharmacogenetics of Drug Metabolism: Overview
175
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
175
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
295
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
295
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
142
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
142
01:52Regression Toward the Mean
7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K